These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10658181)

  • 1. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular trafficking of the JNCL protein CLN3.
    Haskell RE; Derksen TA; Davidson BL
    Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Batten disease with the yeast Saccharomyces cerevisiae.
    Pearce DA; Sherman F
    Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLN3, the protein associated with batten disease: structure, function and localization.
    Phillips SN; Benedict JW; Weimer JM; Pearce DA
    J Neurosci Res; 2005 Mar; 79(5):573-83. PubMed ID: 15657902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue expression and subcellular localization of CLN3, the Batten disease protein.
    Margraf LR; Boriack RL; Routheut AA; Cuppen I; Alhilali L; Bennett CJ; Bennett MJ
    Mol Genet Metab; 1999 Apr; 66(4):283-9. PubMed ID: 10191116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro.
    Kida E; Kaczmarski W; Golabek AA; Kaczmarski A; Michalewski M; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):265-71. PubMed ID: 10191113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical localization of the Batten disease (CLN3) protein in retina.
    Katz ML; Gao CL; Prabhakaram M; Shibuya H; Liu PC; Johnson GS
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2375-86. PubMed ID: 9344361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
    Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
    Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
    Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for phosphorylation of CLN3 protein associated with Batten disease.
    Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE
    Biochem Biophys Res Commun; 1998 Dec; 253(2):458-62. PubMed ID: 9878558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational modification of CLN3 protein and its possible functional implication.
    Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):272-6. PubMed ID: 10191114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A murine model for juvenile NCL: gene targeting of mouse Cln3.
    Greene ND; Bernard DL; Taschner PE; Lake BD; de Vos N; Breuning MH; Gardiner RM; Mole SE; Nussbaum RL; Mitchison HM
    Mol Genet Metab; 1999 Apr; 66(4):309-13. PubMed ID: 10191119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression studies of CLN3 protein (battenin) in fusion with the green fluorescent protein in mammalian cells in vitro.
    Golabek AA; Kaczmarski W; Kida E; Kaczmarski A; Michalewski MP; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):277-82. PubMed ID: 10191115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression studies of CLN3 protein.
    Kaczmarski W; Kida E; Lach A; Rubenstein R; Zhong N; Wisniewski KE
    Neuropediatrics; 1997 Feb; 28(1):33-6. PubMed ID: 9151318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of membrane association of CLN3 protein.
    Kaczmarski W; Wisniewski KE; Golabek A; Kaczmarski A; Kida E; Michalewski M
    Mol Genet Metab; 1999 Apr; 66(4):261-4. PubMed ID: 10191112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.